GlassScriptPhysician profile
Joanna Mcgetrick
NPI 1184940777
$11,688.62
in general payments reported to CMS, 2019-2025
36 companies · $1,869 in 2025
The $1,869 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $714 · 2020: $72.00 · 2021: $2,028 · 2022: $3,015 · 2023: $2,182 · 2024: $1,808 · 2025: $1,869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,658 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,092 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,657.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,092.00 |
| Education | $109.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,959.34 | 2019-2025 | |
| Allergan, INC. | $2,807.92 | 2021-2023 | |
| Janssen Biotech, INC. | $1,017.88 | 2019-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $761.04 | 2019-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $608.62 | 2019-2025 | Ebglyss, Olumiant, Taltz |
| Genzyme Corporation | $553.86 | 2019-2025 | |
| Incyte Corporation | $394.18 | 2021-2025 | Opzelura |
| Ucb, INC. | $299.14 | 2022-2025 | Bimzelx |
| Pfizer INC. | $254.75 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $222.50 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $210.59 | 2023-2024 | Sotyktu |
| Leo Pharma INC. | $198.86 | 2021-2025 | Adbry |
| Novartis Pharmaceuticals Corporation | $196.55 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.24 | 2022-2024 | Spevigo |
| Dermavant Sciences, INC. | $168.91 | 2023 | Vtama |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $162.12 | 2024-2025 | |
| Galderma Laboratories, L.P. | $90.51 | 2025 | Nemluvio |
| Relievant Medsystems, INC. | $85.54 | 2023 | Intracept |
| Celgene Corporation | $81.06 | 2019 | |
| Mayne Pharma Commercial LLC | $68.32 | 2019-2021 | |
| Almirall LLC | $50.80 | 2022-2025 | Klisyri |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.81 | 2019-2025 | Cabtreo, Jublia |
| Amgen INC. | $29.80 | 2022-2023 | Otezla |
| Paratek Pharmaceuticals, INC. | $27.84 | 2025 | Nuzyra |
| Strata Skin Sciences, INC. | $24.74 | 2019-2021 | |
| Verrica Pharmaceuticals INC. | $24.58 | 2023 | Ycanth |
| Convatec INC. | $23.90 | 2024 | |
| Journey Medical Corporation | $21.25 | 2022 | |
| Promius Pharma LLC | $20.38 | 2019 | |
| Dermira, INC. | $18.91 | 2019 | |
| Organogenesis INC. | $18.84 | 2024 | Affinity |
| Biofrontera INC. | $17.86 | 2019 | |
| Sensus Healthcare, INC. | $15.62 | 2019 | |
| Encore Dermatology INC. | $14.68 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.03 | 2019 | |
| Botanix Sb INC | $13.65 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanna Mcgetrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.